Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC
- First Posted Date
- 2013-07-12
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01897610
- Locations
- π°π·
Inha University Hospital, Incheon, Korea, Republic of
π°π·Yonsei University Health System, Seoul, Korea, Republic of
π°π·Korea University Anam Hospital, Seoul, Korea, Republic of
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2013-07-01
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 162
- Registration Number
- NCT01890291
- Locations
- π°π·
Seoul National Hospital, Seoul, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Korea, Republic of
π°π·Asan Medical Center, Seoul, Korea, Republic of
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT00965718
- Locations
- π°π·
Yonsei medical center, Seoul, Korea, Republic of
Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
- Conditions
- Glioblastoma
- Interventions
- Drug: Activated T lymphocyte(Immuncell-LC)
- First Posted Date
- 2008-12-11
- Last Posted Date
- 2012-10-25
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 180
- Registration Number
- NCT00807027
- Locations
- π°π·
Hanyang University Guri Hospital, Guri, Gyeonggi-Do, Korea, Republic of
π°π·Gyunghee University Medical Center, Seoul, Korea, Republic of
π°π·Konkuk University, Seoul, Korea, Republic of
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- GC Cell Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT00699816
- Locations
- π°π·
Korea University Ansan Hospital, Ansan si, Gojan1-dong/Danwon-gu, Korea, Republic of
π°π·Korea University Guro Hospital, Seoul, Guro 2-Dong, Guro-Gu, Korea, Republic of
π°π·Samsung Medical Center, Seoul, Ilwon-dong/Gangnam-gu, Korea, Republic of